Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Journal1
- Article Type
- Clinical Trial1
- Randomized Controlled Trial1
- Clinical Study1
- Comparative Study1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- J Int Med Res1
Search Results
Sort by
- BookJoseph Loscalzo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson.Summary: "This book presents a sharp focus on the clinical presentation of disease, expert in-depth summaries of pathophysiology and treatment, and includes highlights of emerging frontiers of science and medicine"-- Provided by publisher.
- ArticleCecchini S, Petri P, Ardito R, Bareggi SR, Torriti A.J Int Med Res. 1978;6(5):388-94.On the grounds of pharmacological properties and preliminary clinical trials the efficacy of the new antidepressant caroxazone was compared to amitriptyline in the management of depression. Forty patients mostly suffering from a neurotic or anxious-neurotic depression were admitted to a double-blind trial. All patients completed the study. The Hamilton Rating Scale for Depression was used for the clinical assessment at the beginning, during and at the end of treatment. The trial lasted three weeks. A significant improvement was seen for both drugs after seven days on most symptom scores and on total symptom score. No significant differences were found either at seven days of at the end of treatment between the two drugs. There were no significant differences in the incidence and severity of side-effects. In conclusion, caroxazone appears as an effective and well tolerated drug in the treatment of depression.